Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Anthony J Filiano
Associate Professor in Neurosurgery
Neurosurgery
anthony.filiano@duke.edu
DUMC 3350, Durham, NC 27710
701 W. Main St, Chesterfield Bldg Room 5424, Durham, NC 27701
Scholarly Works
More About This Person
glance {hide_children: true, active: false, enabled: true}
At a Glance
credentials {hide_children: true, active: false, enabled: true}
Credentials
Education
academic-experience {hide_children: true, active: false, enabled: true}
Academic Experience
Current Duke Appointments & Affiliations
Professional Training & Employment
global-scholarship {hide_children: true, active: false, enabled: false}
Global Scholarship
keywords {hide_children: true, active: false, enabled: false}
Keywords
research {hide_children: true, active: false, enabled: false}
Research
scholarly-works {hide_children: false, active: true, enabled: true}
Scholarly Works
Featured Works
Conferences
Journal articles
teaching-mentoring {hide_children: true, active: false, enabled: true}
Teaching & Mentoring
Recent Courses
recognition {hide_children: true, active: false, enabled: true}
Recognition
News Items
professional-activities {hide_children: true, active: false, enabled: true}
Professional Activities
Duke Initiatives
Manage Profile
Embed Profile Data
Manage Profile
Embed Profile Data
Scholarly Works - Conferences
DEVELOPING A POTENCY ASSAY FOR CORD TISSUE MESENCHYMAL STROMAL CELLS
Conference
CYTOTHERAPY
·
June 2023
Link to item
Cite
UMBILICAL CORD-DERIVED MESENCHYMAL STROMAL CELLS SUPPRESS MICROGLIA ACTIVATION INDUCED BY DEMYELINATION
Conference
CYTOTHERAPY
·
June 2023
Link to item
Cite
CORD BLOOD DERIVED MACROPHAGES RELEASE FACTORS TO PROMOTE REMYELINATION
Conference
CYTOTHERAPY
·
June 2023
Link to item
Cite
PERICYTES: A NEW CELL THERAPY TOOL FOR REPROGRAMMING NEUROINFLAMMATION
Conference
CYTOTHERAPY
·
May 2022
Link to item
Cite
HUMAN UMBILICAL CORD BLOOD DERIVED CELL THERAPY PRODUCT, DUOC-01, PROMOTES REMYELINATION BY DRIVING THE DIFFERENTIATION OF OPC
Conference
CYTOTHERAPY
·
May 2022
Link to item
Cite
MICROGLIAL SUPPRESSION ASSAYS FOR CELL THERAPIES
Conference
CYTOTHERAPY
·
May 2021
Link to item
Cite
MESENCHYMAL STROMAL CELLS REPROGRAM MACROPHAGES WITH PROCESSING BODIES
Conference
CYTOTHERAPY
·
May 2021
Link to item
Cite
Developing a novel thymus organoid as a cell therapy to correct autoimmunities
Conference
CYTOTHERAPY
·
May 2020
Link to item
Cite
Reprogramming inflammatory macrophages with mesenchymal stromal cells
Conference
CYTOTHERAPY
·
May 2020
Link to item
Cite
DUOC-01, a cord blood derived cell therapy product, ameliorates experimental autoimmune encephalomyelitis, a murine model for multiple sclerosis
Conference
CYTOTHERAPY
·
May 2020
Link to item
Cite
Human umbilical cord blood derived cell therapy product, DUOC-01, ameliorates experimental autoimmune encephalomyelitis, a mouse model for multiple sclerosis
Conference
Cytotherapy
·
May 2019
Full text
Cite
Manufacturing of allogeneic human cord tissue mesenchymal stromal cells: Initial results of a phase I clinical trial in children with autism spectrum disorder
Conference
Cytotherapy
·
May 2018
Full text
Cite
